Hypothesis

Chronic metabolic stress in aged osteocytes triggers a selective autophagy program that prioritizes survival by degrading components of the vitamin K cycle and mineral‑vesicle trafficking machinery. This “rationing” reduces γ‑carboxylation of osteocalcin and impairs regulated mineral deposition, leading to undercarboxylated osteocalcin accumulation, enlarged hydroxyapatite crystals, and deteriorated bone matrix quality.

Mechanistic Rationale

1. Autophagy targets vitamin K‑dependent enzymes – Under prolonged nutrient or oxidative stress, autophagosomes preferentially engulf γ‑glutamyl carboxylase (GGCX) and vitamin K epoxide reductase (VKORC1) complexes, lowering intracellular vitamin K recycling efficiency.
2. Consequences for osteocalcin – Reduced GGCX activity decreases the proportion of carboxylated osteocalcin (cOC), increasing the undercarboxylated fraction (ucOC) that has low affinity for hydroxyapatite.
3. Impact on mineral transport – Autophagic degradation of vesicular proteins such as annexin A2 and plasma membrane Ca²⁺‑ATPase (PMCA) hinders the delivery of calcium‑phosphate packages to the extracellular matrix, slowing nucleation and favoring fewer, larger crystal growth events.
4. Feedback loop – Larger, less soluble crystals further stimulate oxidative stress in osteocytes, reinforcing autophagic activation and cementing the rationing state.

Testable Predictions

• Prediction 1: In aged mouse osteocytes, pharmacological inhibition of autophagy (e.g., chloroquine) will increase GGCX and VKORC1 protein levels, raise the cOC/total OC ratio, and reduce ucOC compared with vehicle‑treated controls.
• Prediction 2: Osteocyte‑specific autophagy activation (via overexpression of Atg5) will recapitulate age‑like matrix changes: enlarged hydroxyapatite crystals (measured by synchrotron X‑ray diffraction), decreased bound water content (NMR), and reduced bone tissue‑level hardness (nanoindentation).
• Prediction 3: Supplementation with vitamin K2 (menaquinone‑7) will rescue carboxylation efficiency only when autophagy is pharmacologically blocked, indicating that the defect lies in vitamin K recycling rather than substrate availability.

Experimental Approach

• Model: Use young (3‑month) and aged (24‑month) C57BL/6 mice; isolate primary osteocytes via collagenase/dispase digestion.
• Interventions: Treat cultures with chloroquine (50 µM) or rapamycin (100 nM) for 24 h; transduce aged osteocytes with AAV‑Atg5 or AAV‑shRNA targeting Atg7.
• Readouts:
  • Western blot for GGCX, VKORC1, LC3‑II/I, p62.
  • ELISA for cOC and ucOC in conditioned media.
  • Hydroxyapatite crystal size via transmission electron microscopy and Rutherford backscattering spectroscopy.
  • Bound water proportion using low‑field NMR.
  • Mechanical testing of excised femur cortical strips (three‑point bending).
• Controls: Vehicle, non‑targeting AAV, and age‑matched wild‑type.

Falsifiability

If autophagy inhibition fails to increase GGCX/VKORC1 levels or improve osteocalcin carboxylation, or if activated autophagy does not produce crystal enlargement and reduced bound water, the hypothesis would be refuted. Likewise, if vitamin K2 supplementation restores carboxylation irrespective of autophagy status, the proposed mechanistic link would be weakened.

Implications

Reframing autophagy as a triage‑like rationing system reframes interventions: simply boosting autophagic flux may exacerbate matrix deterioration in bone, whereas modulating selective cargo recognition could preserve vitamin K‑dependent pathways while still clearing damaged organelles.